1
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mishra MV, Andrews DW, Glass J, Evans JJ,
Dicker AP, Shen X and Lawrence YR: Characterization and outcomes of
optic nerve gliomas: A population-based analysis. J Neurooncol.
107:591–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Stark AM, van de Bergh J, Hedderich J,
Mehdorn HM and Nabavi A: Glioblastoma: Clinical characteristics,
prognostic factors and survival in 492 patients. Clin Neurol
Neurosurg. 114:840–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Akhurst RJ and Derynck R: TGF-beta
signaling in cancer-a double-edged sword. Trends Cell Biol.
11:S44–S51. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Han J, Alvarez-Breckenridge CA, Wang QE
and Yu J: TGF-β signaling and its targeting for glioma treatment.
Am J Cancer Res. 5:945–955. 2015.PubMed/NCBI
|
8
|
Yuan J, Yang F, Wang F, Ma JZ, Guo YJ, Tao
QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MM, Fu WM and Zhang JF: LncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang J, Tian XJ and Xing J: Signal
transduction pathways of EMT induced by TGF-β, SHH, and WNT and
their crosstalks. J Clin Med. 5:E412016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P
and Wu JW: Long noncoding RNA MALAT1 associates with the malignant
status and poor prognosis in glioma. Tumor Biol. 36:3355–3359.
2015. View Article : Google Scholar
|
15
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kros JM, Mustafa DM, Dekker LJ, Sillevis
Smitt PA, Luider TM and Zheng PP: Circulating glioma biomarkers.
Neuro Oncol. 17:343–360. 2015.PubMed/NCBI
|
17
|
Pan W, Gu W, Nagpal S, Gephart MH and
Quake SR: Brain tumor mutations detected in cerebral spinal fluid.
Clin Chem. 61:514–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Westphal M and Lamszus K: Circulating
biomarkers for gliomas. Nat Rev Neurol. 11:556–566. 2015.
View Article : Google Scholar : PubMed/NCBI
|